Wednesday, June 10, 2026

Intelligence Β· INN directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed 4,797
Companies 1,769
Pipeline programs 20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 92 of 200 Β· By data quality, then INN

  1. paramethadione

    PARADIONE

    ORAL FDA: approved

  2. paramethasone acetate

    HALDRONE

    ORAL FDA: approved

  3. pargyline hydrochloride

    EUTONYL

    ORAL FDA: approved

  4. paromomycin sulfate

    HUMATIN

    ORAL FDA: approved

  5. paroxetine mesylate

    PEXEVA

    ORAL FDA: approved

  6. pasireotide diaspartate

    SIGNIFOR

    SUBCUTANEOUS FDA: approved

  7. pasireotide pamoate

    SIGNIFOR PARTIAL CHANGE APPROVAL

    INTRAMUSCULAR FDA: approved Β· PMDA: approved

  8. patiromer sorbitex calcium

    VELTASSA

    ORAL FDA: approved

  9. pegademase bovine

    ADAGEN

    INJECTION FDA: approved

  10. pegaptanib sodium

    MACUGEN

    INTRAVITREAL FDA: approved Β· PMDA: approved

  11. pegfilgrastim-apgf

    NYVEPRIA

    INJECTION FDA: approved

  12. pegfilgrastim-bmez

    ZIEXTENZO

    INJECTION FDA: approved

  13. pegfilgrastim-fpgk

    STIMUFEND

    INJECTION FDA: approved

  14. pegfilgrastim-jmdb

    FULPHILA

    INJECTION FDA: approved

  15. pegfilgrastim-pbbk

    FYLNETRA

    INJECTION FDA: approved

  16. pegfilgrastim-pccg

    ENNUMO

    SUBCUTANEOUS FDA: approved

  17. pegfilgrastim-unne

    ARMLUPEG

    SOLUTION FDA: approved

  18. peginterferon alfa-2a

    PEGASYS

    SUBCUTANEOUS FDA: approved Β· EMA: approved Β· TGA: approved

    L03AB11
  19. peginterferon beta-1a

    PLEGRIDY Biogen

    INJECTION FDA: approved Β· EMA: approved Β· TGA: approved

    L03AB13
  20. pegloticase

    KRYSTEXXA

    INJECTION FDA: approved Β· EMA: withdrawn

    M04AX02
  21. pegulicianine acetate

    LUMISIGHT

    INTRAVENOUS FDA: approved

  22. pegunigalsidase alfa-iwxj

    ELFABRIO

    SINGLE-USE FDA: approved

  23. pegvisomant

    SOMAVERT Pfizer Australia Pty Ltd

    SUBCUTANEOUS FDA: approved Β· EMA: approved Β· TGA: approved

    H01AX01
  24. pegzilarginase-nbln

    LOARGYS

    INJECTION FDA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles β€” INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page β€” it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.